Keywords: AstraZeneca, Russia, Investment, Growth

AstraZeneca puts big hopes on Russia, planning to return to growth in 2014

Article | 08 August 2011

Print This

The Russian market currently remains one of the most promising for further development of AstraZeneca (LSE: AZN), David Brennan, chief ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in